查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553704

骨生長刺激產品市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2024-2030 年

Bone Growth Stimulators Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

骨生長刺激產品市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，骨生長刺激產品的全球市場規模預計將達到 15.3 億美元。

預計2024年至2030年該市場將以5.1%的複合年成長率成長。對非侵入性和微創治療的需求不斷成長是預測期內推動市場成長的關鍵因素。微創手術的好處包括切口更小、感染疾病風險更低、恢復更快、住院時間更短、疤痕更少以及手術期間失血更少。因此，骨形成蛋白（BMP）和富血小板血漿（PRP）在微創脊椎和整形外科手術中的採用率預計將很高，從而推動市場成長。

預計創傷和事故案例的增加也將成為支持骨生長刺激產品市場成長的主要因素。據世界衛生組織稱，每年約有 2,000 萬至 5,000 萬人在道路事故中受傷。道路交通事故和創傷可能導致骨折延遲或不癒合以及嚴重的脊椎損傷，預計這將推動對骨生長刺激產品的需求。

骨生長刺激產品市場報告亮點

  • 由於對患者非侵入性治療和產品進步的高需求，骨骼生長刺激器細分市場將成為 2023 年市場上收益最高的細分市場。
  • 由於 PRP 領域在骨骼和軟組織癒合方面的日益普及、良好的安全性以及在再生治療開發中具有良好成果的潛力，因此在估計和預測期內，PRP 領域將以最高的複合年成長率成長。
  • 就應用領域而言，由於脊椎損傷、骨折和脊椎狹窄的增加，脊椎融合手術領域預計將在2023年佔據最大佔有率，並在預測期內保持其主導地位。
  • 醫院部門在整個市場中佔據最大佔有率，由於遭受外傷、道路事故、脊椎損傷和骨折的患者入院數量不斷增加，預計在研究期間將保持其主導地位。
  • 北美在2023年主導整個市場的主要原因是該地區擁有幾家大型醫療設備公司和高度發展的醫療基礎設施。
  • 預計亞太地區骨生長刺激產品市場將在預測期內呈現最高成長率。包括中國、印度和印尼在內的亞洲國家道路交通事故數量的增加和醫療基礎設施的發展是促進該地區成長的主要因素。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章全球骨生長刺激產品市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球骨骼生長刺激產品市場分析工具
    • 波特的分析
    • PESTEL分析

第4章全球骨生長刺激產品市場：依產品估計與趨勢分析

  • 細分儀表板
  • 骨骼生長刺激產品市場：2023 年和 2030 年產品變化分析
  • 骨骼生長促效劑
  • 骨形成蛋白（BMP）
  • 富血小板血漿 (PRP)

第5章全球骨生長刺激產品市場：按應用估計和趨勢分析

  • 細分儀表板
  • 骨骼生長刺激產品市場：2023 年和 2030 年應用變化分析
  • 脊椎融合手術
  • 骨折延遲癒合和不癒合骨折
  • 整形外科創傷手術
  • 其他

第6章骨生長刺激產品市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 骨骼生長刺激產品市場：2023 年和 2030 年最終用途的變化分析
  • 醫院
  • 整形外科診所
  • 居家照護環境
  • 門診手術中心

第7章全球骨生長刺激產品市場：區域估計與趨勢分析

  • 2023 年及 2030 年骨生長刺激器市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
  • Orthofix Holdings, Inc.
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • Medtronic
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • Zimmer Biomet
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • DePuy Synthes
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • Arthrex, Inc.
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • Bioventus
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • DJO Global, Inc.
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • Ossatec benelux
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • Altis biologics
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • BTT health GMBH
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
  • IGEA
    • 參與企業概況
    • 財務表現
    • 產品基準
  • Isto Biologics
    • 參與企業概況
    • 財務表現
    • 產品基準
    • 最新趨勢/策略舉措
簡介目錄
Product Code: GVR-1-68038-585-4

Bone Growth Stimulators Market Growth & Trends:

The global bone growth stimulators market size is anticipated to reach USD 1.53 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Escalating demand for noninvasive and minimally invasive treatments is a major factor estimated to boost market growth during the forecast period. Some advantages offered by minimally invasive surgeries are smaller incisions, low risk of infections, speedy recovery, shorter stay at the hospital, reduced scarring, and minimal blood loss during surgery. Thus, there is high adoption of Bone Morphogenetic Proteins (BMP) and Platelet-rich Plasma (PRP) for minimally invasive spinal and orthopedic surgeries, which is expected to boost the market growth.

The rising number of trauma and accident cases is another major factor projected to support the growth of the bone growth stimulator market. According to WHO, around 20 to 50 million people are injured every year due to road accidents. Road accidents and trauma are likely to result in severe spinal injuries as well as delayed union or nonunion of bone fractures, which is projected to drive demand for bone growth stimulators.

Bone Growth Stimulators Market Report Highlights:

  • Bone growth stimulation devices segment was the largest revenue grossing segment of the market in 2023 owing to high demand for noninvasive treatments by patients as well as product advancements.
  • PRP segment is estimated to grow at the highest CAGR during the forecast period owing to its growing popularity for bone and soft tissue healing, as well as its favorable safety profile and potential promising outcome for the development of regenerative treatments.
  • In the application segment, the spinal fusion surgeries segment accounted for the largest share in 2023 and is projected to maintain its dominance during the forecast period owing to the escalating number of spinal injuries, fractures, and spinal stenosis.
  • The hospitals segment accounted for the largest share in the overall market and is expected to maintain its dominance during the study period due to escalating number of admissions of patients suffering from traumatic injuries, road accidents, spinal injuries, and bone fractures.
  • North America dominated the overall market in 2023 mainly due to the existence of several leading medical device companies in this region and highly developed healthcare infrastructure.
  • The Asia Pacific bone growth stimulator market is projected to grow at the highest rate during the forecast period. The rising number of road accidents and developing healthcare infrastructure in Asian countries, including China, India, and Indonesia, are major factors contributing to growth in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Bone Growth Stimulators Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Bone Growth Stimulators Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Bone Growth Stimulators Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bone Growth Stimulators Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Bone growth stimulation devices
    • 4.3.1. Bone Growth Stimulation Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Bone Morphogenetic Proteins (BMP)
    • 4.4.1. Bone Morphogenetic Proteins (BMP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Platelet-Rich Plasma (PRP)
    • 4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Global Bone Growth Stimulators Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bone Growth Stimulators Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Spinal fusion surgeries
    • 5.3.1. Spinal fusion surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Delayed union & nonunion bone fractures
    • 5.4.1. Delayed union & nonunion bone fractures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Orthopedic trauma surgeries
    • 5.5.1. Orthopedic trauma surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Other Accessories
    • 5.6.1. Other Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Globe Bone Growth Stimulators Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Bone Growth Stimulators Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Specialized Orthopedic Clinics
    • 6.4.1. Specialized Orthopedic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Home Care Settings
    • 6.5.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Ambulatory Surgical Centers
    • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Globe Bone Growth Stimulators Market: Regional Estimates & Trend Analysis

  • 7.1. Bone Growth Stimulators Market Share, By Region, 2023 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. China
      • 7.4.2.1. China Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. India Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
  • 8.5. Orthofix Holdings, Inc.
    • 8.5.1. Participant's Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments/ Strategic Initiatives
  • 8.6. Medtronic
    • 8.6.1. Participant's Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments/ Strategic Initiatives
  • 8.7. Zimmer Biomet
    • 8.7.1. Participant's Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments/ Strategic Initiatives
  • 8.8. DePuy Synthes
    • 8.8.1. Participant's Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments/ Strategic Initiatives
  • 8.9. Arthrex, Inc.
    • 8.9.1. Participant's Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments/ Strategic Initiatives
  • 8.10. Bioventus
    • 8.10.1. Participant's Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments/ Strategic Initiatives
  • 8.11. DJO Global, Inc.
    • 8.11.1. Participant's Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Developments/ Strategic Initiatives
  • 8.12. Ossatec benelux
    • 8.12.1. Participant's Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Developments/ Strategic Initiatives
  • 8.13. Altis biologics
    • 8.13.1. Participant's Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Developments/ Strategic Initiatives
  • 8.14. BTT health GMBH
    • 8.14.1. Participant's Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Recent Developments/ Strategic Initiatives
  • 8.15. IGEA
    • 8.15.1. Participant's Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
  • 8.16. Isto Biologics
    • 8.16.1. Participant's Overview
    • 8.16.2. Financial Performance
    • 8.16.3. Product Benchmarking
    • 8.16.4. Recent Developments/ Strategic Initiatives